Calling all livestreamers … we need you! In the time of a 4-hour stream, 10 women are diagnosed with ovarian cancer. That’s a new diagnosis every 23 minutes. Join us this August as we partner with Tiltify to help unlock a cure for the #1 cause of gynecologic cancer deaths. Funds raised through #GameOVAR charity … Continued
Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant. With his project, “Understanding and Targeting Myeloid Populations in Ovarian Cancer,” Dr. Cannon seeks to better understand the behavior of a type of immune cell that currently helps ovarian cancer tumors grow, in order … Continued
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month. Below, we highlight breakthroughs in our understanding and treatment of ovarian cancer, thanks to the ongoing work of our grantees. And be sure to keep scrolling down to discover new ways to get involved and get support! Research … Continued
The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: NEW YORK, May 11, 2022 — The Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA) announced today that the first patients have been dosed in their new multi-center platform clinical trial testing novel cancer immunotherapy combinations in patients … Continued
Many exciting updates about progress against ovarian cancer were presented at this year’s Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer — the largest meeting of gynecologic cancer experts in the world. This April, gynecologic oncologist and ovarian cancer expert Dr. Sarah Adams joined OCRA for an interactive webinar reporting on the highlights (in … Continued
As the busy summer months approach, OCRA remains committed to expanding support and offering new opportunities for our community to engage with others impacted by ovarian or other gynecologic cancers. With that in mind, we are happy to launch the first Staying Connected: Summer Series. This new series of online support groups will focus on specific … Continued
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for our community’s help in collecting signatures on a bipartisan Dear Colleague letter in the House of Representatives requesting a major funding increase to the Ovarian … Continued
Mother’s Day signifies so much to so many—celebration, gratitude, and yes, remembrance or loss. This year, we want to acknowledge just some of our many supporters who have taken their love for their moms and transformed it into a gift for our entire community. Whether biking across the country or putting on a virtual play, … Continued
The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania and Cedars-Sinai Medical Center and their colleagues. The learnings, which were published in Science Signaling, may pave the way for the future development of new targeted therapies. HGSOC … Continued
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of the University of California, San Diego Moores Cancer Center. High-grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, with approximately 75% of epithelial ovarian cancers … Continued
Audra Moran, President and CEO of OCRA, and Richard Pazdur, MD, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer during a recent discussion. Topics that were covered include the critical role that patients play in research, drug regulation, and the policies that affect the … Continued
Get email updates about research news, action alerts, and ways to join the fight.
